AXIM BIOTECHNOLOGIES, INC. cotiza a 0.00 USD y tiene una capitalización bursátil de $1M. En los últimos 12 meses ha facturado $92898 con un margen de flujo de caja libre del -2607.7%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
AXIM Biotechnologies, Inc. develops diagnostic healthcare solutions for ophthalmological conditions. It develops and commercializes two point-of-care diagnostic tests to assist eye-care physicians in detecting and quantifying biomarkers associated with aqueous deficient dry eye disease and non-specific allergic conjunc…
| Métrica | AXIM | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -6961.0% | -38.6% | -6922.4% |
| Net Margin | -20395.0% | -33.6% | -20361.4% |
| FCF Margin | -2607.7% | -13.9% | -2593.8% |
| ROE | — | -40.4% | — |
| ROA | -195.6% | -32.0% | -163.5% |
| Current Ratio | 0.03 | 2.84 | -2.81 |
| Debt / Equity | — | 0.28 | — |